Expression Therapeutics LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- 11
- Market Cap
- -
Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A
Phase 1
Not yet recruiting
- Conditions
- Hemophilia A
- Interventions
- Drug: Gene therapyOther: Biological
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Expression Therapeutics, LLC
- Target Recruit Count
- 7
- Registration Number
- NCT04418414
© Copyright 2025. All Rights Reserved by MedPath